Viking Therapeutics, Inc. (VKTX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.54B; Treasury Stock, ValueUSD (m); AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD $-1.15M.
- 2026-03-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.51B; Treasury Stock, ValueUSD (m); AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD $-856.00K.
- 2025-12-31: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.49B; Treasury Stock, ValueUSD $0.00; AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD $378.00K.
- 2025-09-30: Common Stock, Value, IssuedUSD $1.00K; Additional Paid in Capital, Common StockUSD $1.40B; Treasury Stock, ValueUSD $0.00; AOCI, Debt Securities, Available-for-sale, Adjustment, after TaxUSD $374.00K.
Viking Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Treasury Stock, Value USD | AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K | $1.54B | (m) | $-1.15M | $-1.13B | $408.32M | $408.32M | (m) | (m) | 3 month · $11.13M 6 month · $21.47M | (m) | (m) |
| 2026-03-31 | $1.00K | $1.51B | (m) | $-856.00K | $-1.01B | $501.92M | $501.92M | (m) | (m) | 3 month · $10.34M | (m) | (m) |
| 2025-12-31 | $1.00K | $1.49B | $0.00 | $378.00K | $-847.55M | $639.06M | $639.06M | 0.00 | (m) | 12 month · $40.82M | (m) | (m) |
| 2025-09-30 | $1.00K | $1.40B | $0.00 | $374.00K | $-689.88M | $713.03M | $713.03M | 0.00 | (m) | 3 month · $7.34M 9 month · $32.23M | (m) | (m) |
| 2025-06-30 | $1.00K | $1.39B | $0.00 | $-166.00K | $-599.10M | $795.46M | $795.46M | 0.00 | (m) | 3 month · $13.55M 6 month · $24.89M | (m) | (m) |
| 2025-03-31 | $1.00K | $1.38B | $0.00 | $-216.00K | $-533.54M | $846.92M | $846.92M | 0.00 | (m) | 3 month · $11.35M | (m) | (m) |
| 2024-12-31 | $1.00K | $1.37B | $0.00 | $-788.00K | $-487.91M | $880.28M | $880.28M | 0.00 | (m) | 12 month · $29.71M | (m) | (m) |
| 2024-09-30 | $1.00K | $1.36B | $0.00 | $1.63M | $-452.49M | $911.45M | $911.45M | 0.00 | (m) | 3 month · $8.98M 9 month · $24.05M | (m) | (m) |
| 2024-06-30 | $1.00K | $1.35B | $0.00 | $-2.27M | $-427.55M | $920.98M | $920.98M | 0.00 | (m) | 3 month · $7.08M 6 month · $15.06M | (m) | (m) |
| 2024-03-31 | $1.00K | $1.34B | $0.00 | $-1.60M | $-405.30M | $933.89M | $933.89M | 0.00 | (m) | 3 month · $7.98M | (m) | (m) |
| 2023-12-31 | $1.00K | $733.55M | $6.79M | $-389.00K | $-377.94M | $348.42M | $348.42M | 2.19M | (m) | 12 month · $16.75M | (m) | (m) |
| 2023-09-30 | $1.00K | $729.28M | $6.79M | $-905.00K | $-353.34M | $368.24M | $368.24M | 2.19M | (m) | 3 month · $4.48M 9 month · $12.67M | (m) | (m) |
| 2023-06-30 | $1.00K | $724.75M | $6.79M | $-1.04M | $-330.81M | $386.12M | $386.12M | 2.19M | (m) | 3 month · $4.62M 6 month · $8.19M | (m) | (m) |
| 2023-03-31 | $1.00K | $453.06M | $6.79M | $-618.00K | $-311.58M | $134.06M | $134.06M | (m) | (m) | 3 month · $3.57M | (m) | 2.19M |
| 2022-12-31 | $1.00K | $445.27M | $6.79M | $-1.10M | $-292.05M | $145.32M | $145.32M | 2.19M | 12 month · $6.79M | 12 month · $8.67M | (m) | 2.19M |
| 2022-09-30 | $1.00K | $432.33M | $6.79M | $-1.76M | $-272.49M | $151.28M | $151.28M | (m) | 9 month · $6.79M | 3 month · $1.94M 9 month · $6.52M | (m) | 2.19M |
| 2022-06-30 | $1.00K | $430.39M | $6.79M | $-1.65M | $-256.72M | $165.23M | $165.23M | (m) | 3 month · $1.67M 6 month · $6.79M | 3 month · $2.22M 6 month · $4.58M | (m) | 2.19M |
| 2022-03-31 | $1.00K | $428.09M | $5.12M | $-1.41M | $-239.28M | $182.27M | $182.27M | (m) | 3 month · $5.12M | 3 month · $2.36M | (m) | 1.46M |
| 2021-12-31 | $1.00K | $425.61M | (m) | $-549.00K | $-223.18M | $201.88M | $201.88M | (m) | (m) | 12 month · $6.10M | (m) | 0.00 |
| 2021-09-30 | $1.00K | $424.12M | (m) | $-170.00K | $-210.83M | $213.12M | $213.12M | (m) | (m) | 3 month · $1.60M 9 month · $4.67M | (m) | (m) |
| 2021-06-30 | $1.00K | $422.75M | (m) | $-189.00K | $-197.58M | $224.97M | $224.97M | (m) | (m) | 3 month · $1.49M 6 month · $3.07M | (m) | (m) |
| 2021-03-31 | $1.00K | $419.53M | (m) | $-104.00K | $-182.20M | $237.22M | $237.22M | (m) | (m) | 3 month · $1.58M | (m) | (m) |
| 2020-12-31 | $1.00K | $412.59M | (m) | $-54.00K | $-168.19M | $244.34M | $244.34M | (m) | (m) | 12 month · $5.82M | (m) | (m) |
| 2020-09-30 | $1.00K | $411.08M | (m) | $-46.00K | $-157.24M | $253.79M | $253.79M | (m) | (m) | 3 month · $1.48M 9 month · $4.78M | (m) | (m) |
| 2020-06-30 | $1.00K | $409.57M | (m) | $333.00K | $-147.96M | $261.95M | $261.95M | (m) | (m) | 3 month · $1.65M 6 month · $3.30M | (m) | (m) |
| 2020-03-31 | $1.00K | $407.48M | (m) | $-812.00K | $-138.38M | $268.28M | $268.28M | (m) | (m) | 3 month · $1.65M | (m) | (m) |
| 2019-12-31 | $1.00K | $405.80M | (m) | $12.00K | $-128.70M | $277.12M | $277.12M | (m) | (m) | 12 month · $3.59M | (m) | (m) |
| 2019-09-30 | $1.00K | $404.58M | (m) | $157.00K | $-121.25M | $283.49M | $283.49M | (m) | (m) | 3 month · $810.00K 9 month · $2.64M | (m) | (m) |
| 2019-06-30 | $1.00K | $403.63M | (m) | $239.00K | $-115.52M | $288.35M | $288.35M | (m) | (m) | 3 month · $884.00K 6 month · $1.83M | (m) | (m) |
| 2019-03-31 | $1.00K | $402.46M | (m) | $-49.00K | $-107.84M | $294.57M | $294.57M | (m) | (m) | 3 month · $949.00K | (m) | (m) |
| 2018-12-31 | $1.00K | $401.09M | (m) | $-423.00K | $-102.92M | $297.75M | $297.75M | (m) | (m) | 12 month · $2.48M | (m) | (m) |
| 2018-09-30 | $1.00K | $399.85M | (m) | $-117.00K | $-97.68M | $302.05M | $302.05M | (m) | (m) | 3 month · $747.00K 9 month · $1.89M | (m) | (m) |
| 2018-06-30 | $1.00K | $231.59M | (m) | $-147.00K | $-91.08M | $140.36M | $140.36M | (m) | (m) | 3 month · $531.00K 6 month · $1.14M | (m) | (m) |
| 2018-03-31 | $1.00K | $157.15M | (m) | $-109.00K | $-84.41M | $72.63M | $72.63M | (m) | (m) | 3 month · $610.00K | (m) | (m) |
| 2017-12-31 | $358.00 | $94.34M | (m) | $-20.00K | $-80.86M | $13.46M | $13.46M | (m) | (m) | 12 month · $1.43M | (m) | (m) |
| 2017-09-30 | $285.00 | $79.00M | (m) | $-3.56K | $-76.77M | $2.23M | $2.23M | (m) | (m) | 3 month · $344.00K 9 month · $1.07M | (m) | (m) |
| 2017-06-30 | $277.00 | $77.26M | (m) | $-6.00K | $-70.67M | $6.59M | $6.59M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $239.00 | $73.05M | (m) | $-7.50K | $-65.50M | $7.55M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $208.00 | $68.33M | (m) | $-6.89K | $-60.28M | $8.04M | $8.04M | (m) | (m) | 12 month · $1.79M | (m) | (m) |
| 2016-09-30 | $199.00 | $66.86M | (m) | $-6.14K | $-56.63M | $10.22M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $193.00 | $65.62M | (m) | $-6.79K | $-52.83M | $12.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $97.00 | $54.90M | (m) | $-195.00 | $-49.13M | $5.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $97.00 | $54.28M | (m) | $-7.37K | $-45.55M | $8.72M | $8.72M | (m) | (m) | 12 month · $2.21M | 12 month · $456.41K | (m) |
| 2015-09-30 | $98.00 | $53.73M | (m) | $-4.85K | $-40.45M | $13.27M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $98.00 | $53.12M | (m) | $-12.46K | $-35.72M | $17.39M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-05-04 | (m) | $29.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $60.00 | $13.77K | (m) | (m) | $-27.85M | $-27.84M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $60.00 | $12.87K | (m) | (m) | $-22.14M | $-22.13M | $-22.13M | (m) | (m) | 12 month · $3.76K | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | $-250.60K | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |